| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| GNWGenworth Financial, Inc. | 3.31B | 8.30 | 12.21 | -3.09% | 3.1% | 2.24% | 2.65% | 0.16 |
| MHNCMaiden Holdings North America, Ltd. | 1.58B | 15.87 | -7.90 | -2.92% | -247.48% | -405.36% |
| Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 419.77B | 983.15B | 1.25T | 1.64T | 0 | 98.72M | 58.13M | 56.44M |
| Revenue Growth % | - | 1.34% | 0.27% | 0.31% | -1% | - | -0.41% | -0.03% |
| Medical Costs & Claims | 1.25B | 38.73B | 5.81B | 5.03B | 0 | 0 | 0 | 0 |
| Medical Cost Ratio % | - | - | - | - | - | - | - | - |
| Gross Profit | 418.51B | 944.42B | 1.24T | 1.64T | 0 | 98.72M | 58.13M | 56.44M |
| Gross Margin % | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | 1.26% | 0.32% | 0.32% | -1% | - | -0.41% | -0.03% |
| Operating Expenses | 14.97B | 0 | 42.18B | 53.89B | 8.48M | 36.02M | 118.53M | 35.35M |
| OpEx / Revenue % | - | - | - | - | - | - | - | - |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 8.69M | 19.33M | 228.49K | 0 |
| Combined Ratio % | - | - | - | - | - | - | - | - |
| Operating Income | 403.54B | 62.4B | 1.2T | 1.58T | 8.48M | 26.66M | 75.32M | 21.09M |
| Operating Margin % | - | - | - | - | - | - | - | - |
| Operating Income Growth % | - | -0.85% | 18.23% | 0.32% | -1% | 2.14% | 1.83% | -0.72% |
| EBITDA | 403.54B | 62.4B | 1.2T | 1.58T | 17.17M | 45.99M | 75.55M | 21.09M |
| EBITDA Margin % | - | - | - | - | - | - | - | - |
| Interest Expense | 0 | 34.43B | 36.47B | 34.16B | 0 | 19.33M | 19.33M | 19.27M |
| Non-Operating Income | 0 | 0 | 1.09T | 1.52T | 0 | 0 | 0 | 201.74M |
| Pretax Income | 18.79B | 62.4B | 71.19B | 30.45B | 0 | 26.66M | 55.99M | -199.91M |
| Pretax Margin % | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 1.34B | 1.33B | 1.93B | 0 | 15K | 557K | 1.05M |
| Effective Tax Rate % | - | - | - | - | - | - | - | - |
| Net Income | 18.79B | 61.06B | 69.87B | 28.52B | 0 | 26.64M | 55.43M | -200.97M |
| Net Margin % | - | - | - | - | - | - | - | - |
| Net Income Growth % | - | 2.25% | 0.14% | -0.59% | -1% | - | 1.08% | -4.63% |
| EPS (Diluted) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.31 | 0.64 | -2.01 |
| EPS Growth % | - | - | - | - | - | - | 1.06% | -4.14% |
| EPS (Basic) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.31 | 0.64 | -2.01 |
| Diluted Shares Outstanding | 59.34T | 70.06T | 71.37T | 72.9T | 84.94M | 86.55M | 87.16M | 99.9M |
| Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 2.13B | 2.64B | 2.98B | 3.35T | 2.95M | 2.32M | 1.85M | 1.32B |
| Asset Growth % | - | 0.24% | 0.13% | 1123.55% | -1% | -0.21% | -0.2% | 711.56% |
| Total Investment Assets | 0 | 0 | 0 | 2.02T | 0 | 822.61K | 160.32K | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | -66.09K | 80.16K | 0 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 888.7K | 80.16K | 0 |
| Total Current Assets | 131.9M | 107.4M | 96.2M | 570.75B | 1.46M | 908.21K | 1.09M | 55.54M |
| Cash & Equivalents | 131.9M | 107.4M | 96.2M | 188.08B | 1.46M | 888.7K | 633.68K | 34.73M |
| Receivables | 0 | 0 | 0 | 1000K | 5.78K | 19.51K | 452.12K | 1000K |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 | -888.7K | -80.16K | 0 |
| Goodwill & Intangibles | 0 | 0 | 0 | 98.75B | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 382.67B | 0 | 0 | 0 | 0 |
| PP&E (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 66.09K | 0 | 0 |
| Total Liabilities | 0 | 0 | 0 | 0 | 2.42M | 1.94M | 1.56M | 1.27B |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Debt | -131.9M | -107.4M | -96.2M | -188.08B | -1.46M | -888.66K | -633.68K | -34.73M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 0 | 0 | 1.94M | 0 | 0 |
| Total Equity | 509.8M | 676.5M | 750.2M | 768.98B | 527.82K | 384.26K | 284.58K | 45.19M |
| Equity Growth % | - | 0.33% | 0.11% | 1024.03% | -1% | -0.27% | -0.26% | 157.81% |
| Shareholders Equity | 509.8M | 676.5M | 750.2M | 768.64B | 527.82K | 384.26K | 284.58K | 45.19M |
| Minority Interest | 0 | 0 | 0 | 338M | 0 | 0 | 0 | 0 |
| Retained Earnings | 0 | 0 | 0 | 128.65B | -615.84M | -498.3K | -442.86K | -687.91M |
| Common Stock | 0 | 0 | 0 | 732M | 898K | 923K | 1.49K | 1.5M |
| Accumulated OCI | 0 | 0 | 0 | 64.06B | 23.86K | -12.21K | -41.23K | -32.73M |
| Return on Equity (ROE) | 36.87% | 102.94% | 97.94% | 0.07% | - | 58.43% | 165.76% | -8.84% |
| Return on Assets (ROA) | 8.83% | 25.63% | 24.87% | 0.02% | - | 10.11% | 26.59% | -0.3% |
| Equity / Assets | - | - | - | - | - | - | - | - |
| Debt / Equity | - | - | - | - | - | - | - | - |
| Book Value per Share | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.45 |
| Tangible BV per Share | - | - | - | - | - | - | - | - |
| Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 589.39B | 41.98B | 151.58B | 181.35B | -541.77M | 0 | -195.93M | -67.45M |
| Operating CF Growth % | - | -0.93% | 2.61% | 0.2% | -1% | 1% | - | 0.66% |
| Operating CF / Revenue % | - | - | - | - | - | - | - | - |
| Net Income | 18.79B | 61.06B | 69.86B | 28.53B | 0 | 26.64M | -60.04M | -200.97M |
| Depreciation & Amortization | 1.31B | 7.36B | 7.21B | 8.6B | 8.69M | 0 | 0 | 0 |
| Stock-Based Compensation | -1.7B | -5.47B | -3.59B | 22.24B | 0 | 0 | 0 | -5.26M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 570.98B | -20.96B | 78.1B | 121.99B | -584.02M | -26.09M | -112K | 138.78M |
| Working Capital Changes | 0 | 0 | 0 | 0 | 24.87M | -553.68K | -135.78M | 0 |
| Cash from Investing | -716.93B | -173.43B | -125.19B | 13.25B | 596.04M | 0 | 188.79M | 77.74M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | -108.64B | -13.61B | -4.89B | 635M | 0 | 0 | 0 | 0 |
| Purchase of Investments | -479.24B | -891.47B | -1.03T | -637.31B | -36.82M | 0 | -95.56M | -37.77M |
| Sale/Maturity of Investments | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 1000K | 1000K |
| Other Investing | -458.19B | 531.44B | -710.61B | -374.67B | 127.47M | 0 | 218.74M | 14.57M |
| Cash from Financing | 223.71B | 105.89B | -37.24B | -20.92B | -30.13M | 0 | -10.98M | -3.73M |
| Dividends Paid | -8.93B | -12.65B | -18.39B | -20.92B | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | -1K | 0 | -1.01M | -3.73M |
| Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt Issuance (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 232.65B | 118.54B | -18.84B | 0 | -30.13M | 0 | -10.98M | -3.73M |
| Net Change in Cash | 96.17B | -24.5B | -11.24B | -25.14B | 28.55M | 0 | -19.46M | 5.41M |
| Exchange Rate Effect | 0 | 1000K | -1000K | -1000K | 1000K | 0 | -1000K | -1000K |
| Cash at Beginning | 35.73B | 131.9B | 107.4B | 0 | 107.28M | 135.83M | 66.09M | 42.68M |
| Cash at End | 131.9B | 107.4B | 96.15B | -25.14B | 135.83M | 135.83M | 46.62M | 48.08M |
| Free Cash Flow | 589.39B | 41.98B | 151.58B | 181.35B | -541.77M | 0 | -195.93M | -67.45M |
| FCF Growth % | - | -0.93% | 2.61% | 0.2% | -1% | 1% | - | 0.66% |
| FCF Margin % | - | - | - | - | - | - | - | - |
| FCF per Share | 0.01 | 0 | 0 | 0 | -6.38 | - | -2.25 | -0.68 |
| Metric | 2008 | 2009 | 2010 | 2011 | 2020 | 2021 | 2022 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Combined Ratio | 3.87% | 3.94% | 3.85% | 3.59% | - | 36.49% | 203.89% | 62.63% |
| Medical Cost Ratio | 0.3% | 3.94% | 0.47% | 0.31% | - | 0% | 0% | 0% |
| Return on Equity (ROE) | 3686.54% | 10293.85% | 9794.07% | 7.41% | - | 5842.73% | 16575.66% | -883.82% |
| Return on Assets (ROA) | 882.93% | 2562.5% | 2486.56% | 1.7% | - | 1010.99% | 2658.94% | -30.5% |
| Equity / Assets | 23.95% | 25.66% | 25.15% | 22.93% | 17.9% | 16.54% | 15.41% | 3.43% |
| Book Value / Share | 0 | 0 | 0 | 0.01 | 0.01 | 0 | 0 | 0.45 |
| Revenue Growth | - | 134.21% | 26.94% | 31.44% | -100% | - | -41.11% | -2.92% |
| 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | |
|---|---|---|---|---|---|---|---|
| Diversified Reinsurance | 795.34M | 762.06M | 854.03M | 744.88M | 724.12M | 823.37M | 112.49M |
| Diversified Reinsurance Growth | - | -4.18% | 12.07% | -12.78% | -2.79% | 13.70% | -86.34% |
| AmTrust Reinsurance | - | - | 1.38B | 1.68B | 1.84B | 1.91B | - |
| AmTrust Reinsurance Growth | - | - | - | 22.19% | 9.47% | 3.58% | - |
| AmTrust Quota Share Reinsurance | 727.78M | 988.9M | - | - | - | - | - |
| AmTrust Quota Share Reinsurance Growth | - | 35.88% | - | - | - | - | - |
| NGHC Quota Share | - | 249.92M | - | - | - | - | - |
| NGHC Quota Share Growth | - | - | - | - | - | - | - |
| ACAC Quota Share | 280.66M | - | - | - | - | - | - |
| ACAC Quota Share Growth | - | - | - | - | - | - | - |
Maiden Holdings North America, Ltd. (MHNC) saw revenue decline by 2.9% over the past year.
Maiden Holdings North America, Ltd. (MHNC) reported a net loss of $152.3M for fiscal year 2024.
Maiden Holdings North America, Ltd. (MHNC) has a return on equity (ROE) of -883.8%. Negative ROE indicates the company is unprofitable.
Maiden Holdings North America, Ltd. (MHNC) has a combined ratio of 0.0%. A ratio below 100% indicates underwriting profitability.